Biocon Biologics Plan Molecule Launch Every 1-2 Years

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo   The market share that Biocon......

Price relief for diabetes patients as drugs go off patent

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category......

Consumers may have to pay more for insulin

Popular domestic brands of insulin analog Glargine (the chemical name) are in short supply for the past few months, forcing patients to switch to expensive imported alternatives, it is learnt.......

Big pharma can't raise prices of imported drugs

Drug price regulator National Pharmaceutical Pricing Authority has denied a price rise for some imported products of Sanofi, Novartis, and Allergan.In a meeting earlier this month, the regulator......